262 related articles for article (PubMed ID: 21689064)
1. Emepepimut-S for non-small cell lung cancer.
Corrales-Rodriguez L; Blais N; Soulières D
Expert Opin Biol Ther; 2011 Aug; 11(8):1091-7. PubMed ID: 21689064
[TBL] [Abstract][Full Text] [Related]
2. Tecemotide: an antigen-specific cancer immunotherapy.
Wurz GT; Kao CJ; Wolf M; DeGregorio MW
Hum Vaccin Immunother; 2014; 10(11):3383-93. PubMed ID: 25483673
[TBL] [Abstract][Full Text] [Related]
3. Technology evaluation: BLP-25, Biomira Inc.
Morse MA
Curr Opin Mol Ther; 2001 Feb; 3(1):102-5. PubMed ID: 11249725
[TBL] [Abstract][Full Text] [Related]
4. L-BLP25: a peptide vaccine strategy in non small cell lung cancer.
Sangha R; Butts C
Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4652-4. PubMed ID: 17671159
[TBL] [Abstract][Full Text] [Related]
5. Cancer immunotherapy: phase II clinical studies with TG4010 (MVA-MUC1-IL2).
Acres B
J BUON; 2007 Sep; 12 Suppl 1():S71-5. PubMed ID: 17935281
[TBL] [Abstract][Full Text] [Related]
6. Active immunotherapy for non-small-cell lung cancer: moving toward a reality.
Perez CA; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1599-605. PubMed ID: 21999133
[TBL] [Abstract][Full Text] [Related]
7. A multicenter open-label study to assess the safety of a new formulation of BLP25 liposome vaccine in patients with unresectable stage III non-small-cell lung cancer.
Butts C; Murray RN; Smith CJ; Ellis PM; Jasas K; Maksymiuk A; Goss G; Ely G; Beier F; Soulières D
Clin Lung Cancer; 2010 Nov; 11(6):391-5. PubMed ID: 21071331
[TBL] [Abstract][Full Text] [Related]
8. Vaccines for the treatment of non-small cell lung cancer: investigational approaches and clinical experience.
Mellstedt H; Vansteenkiste J; Thatcher N
Lung Cancer; 2011 Jul; 73(1):11-7. PubMed ID: 21474197
[TBL] [Abstract][Full Text] [Related]
9. Novel targeted agents for lung cancer.
West HJ
Clin Lung Cancer; 2009 Mar; 10 Suppl 1():S41-6. PubMed ID: 19362946
[TBL] [Abstract][Full Text] [Related]
10. Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer.
Hall RD; Gray JE; Chiappori AA
Cancer Control; 2013 Jan; 20(1):22-31. PubMed ID: 23302904
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC
Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457
[TBL] [Abstract][Full Text] [Related]
12. What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?
Reck M
Ann Oncol; 2012 Sep; 23 Suppl 8():viii28-34. PubMed ID: 22918925
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer.
Limacher JM; Spring-Giusti C; Bellon N; Ancian P; Rooke R; Bonnefoy JY
Expert Rev Vaccines; 2013 Mar; 12(3):263-70. PubMed ID: 23496666
[TBL] [Abstract][Full Text] [Related]
14. Harnessing the immune system for the treatment of non-small-cell lung cancer.
Brahmer JR
J Clin Oncol; 2013 Mar; 31(8):1021-8. PubMed ID: 23401435
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in non-small-cell lung carcinoma: from inflammation to vaccination.
Van den Heuvel MM; Burgers SA; van Zandwijk N
Clin Lung Cancer; 2009 Mar; 10(2):99-105. PubMed ID: 19362952
[TBL] [Abstract][Full Text] [Related]
16. Immune-modulating vaccines in non-small cell lung cancer.
Nemunaitis J; Murray N
J Thorac Oncol; 2006 Sep; 1(7):756-61. PubMed ID: 17409955
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor vaccine in non-small-cell lung cancer.
Gonzalez Marinello GM; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2012 Apr; 12(4):439-45. PubMed ID: 22500681
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for lung cancer: ongoing clinical trials.
Declerck S; Vansteenkiste J
Future Oncol; 2014 Jan; 10(1):91-105. PubMed ID: 24143916
[TBL] [Abstract][Full Text] [Related]
19. Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials.
De Pas T; Giovannini M; Rescigno M; Catania C; Toffalorio F; Spitaleri G; Delmonte A; Barberis M; Spaggiari L; Solli P; Veronesi G; De Braud F
Crit Rev Oncol Hematol; 2012 Sep; 83(3):432-43. PubMed ID: 22366114
[TBL] [Abstract][Full Text] [Related]
20. Belagenpumatucel-L for the treatment of non-small cell lung cancer.
Rijavec E; Biello F; Genova C; Barletta G; Maggioni C; Dal Bello MG; Coco S; Truini A; Vanni I; Alama A; Beltramini S; Grassi MA; Boccardo F; Grossi F
Expert Opin Biol Ther; 2015; 15(9):1371-9. PubMed ID: 26211534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]